98 related articles for article (PubMed ID: 24137971)
21. Efficacy, safety and tolerability of salbutamol + guaiphenesin + bromhexine (Ascoril) expectorant versus expectorants containing salbutamol and either guaiphenesin or bromhexine in productive cough: a randomised controlled comparative study.
Prabhu Shankar S; Chandrashekharan S; Bolmall CS; Baliga V
J Indian Med Assoc; 2010 May; 108(5):313-4, 316-8, 320. PubMed ID: 21121410
[TBL] [Abstract][Full Text] [Related]
22. Comparison of lidocaine and bronchodilator inhalation treatments for cough suppression in patients with chronic obstructive pulmonary disease.
Chong CF; Chen CC; Ma HP; Wu YC; Chen YC; Wang TL
Emerg Med J; 2005 Jun; 22(6):429-32. PubMed ID: 15911951
[TBL] [Abstract][Full Text] [Related]
23. [Clinical evaluation of efficacy and tolerance of oral treatment with ambroxol in patients with chronic bronchitis].
Michnar M; Milanowski J
Pneumonol Alergol Pol; 1996; 64 Suppl 1():90-6. PubMed ID: 9190245
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B
Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
[TBL] [Abstract][Full Text] [Related]
25. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
[TBL] [Abstract][Full Text] [Related]
26. [Peculiarities of the treatment of obstructive pulmonary disease in patients with combined pathology].
Klester EB; Shoĭkhet IaN
Klin Med (Mosk); 2009; 87(10):41-6. PubMed ID: 20017350
[TBL] [Abstract][Full Text] [Related]
27. [The clinical efficiency and safety of iodide-bromine balneotherapy in patients with coronary heart disease concurrent with chronic obstructive pulmonary disease].
Zunnunov ZR
Ter Arkh; 2010; 82(1):24-7. PubMed ID: 20364695
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
Le Jemtel TH; Padeletti M; Jelic S
J Am Coll Cardiol; 2007 Jan; 49(2):171-80. PubMed ID: 17222727
[TBL] [Abstract][Full Text] [Related]
29. [Postinfectious cough - a modern view to the pathogenesis and treatment options].
Poniakina MA; Ovchinnikov AIu; Korostelev SA
Vestn Otorinolaringol; 2013; (4):78-81. PubMed ID: 24005278
[TBL] [Abstract][Full Text] [Related]
30. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].
Sleszycka J; Woźniak K; Banaszek M; Wiechno W; Domagała-Kulawik J
Pol Merkur Lekarski; 2009 Aug; 27(158):92-6. PubMed ID: 19856871
[TBL] [Abstract][Full Text] [Related]
31. Impact of chronic obstructive pulmonary diseases on outcomes and hospital days after percutaneous coronary intervention.
Zhang JW; Zhou YJ; Yang Q; Yang SW; Nie B; Xu XH
Angiology; 2013 Aug; 64(6):430-4. PubMed ID: 22942128
[TBL] [Abstract][Full Text] [Related]
32. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
33. [Assessment of periodontal state in patients with chronic obstructive pulmonary disease--part II].
Kowalski M; Kowalska E; Split M; Split W; Wierzbicka-Ferszt A; Pawlicki L; Kowalski J
Pol Merkur Lekarski; 2005 Oct; 19(112):537-41. PubMed ID: 16379320
[TBL] [Abstract][Full Text] [Related]
34. Short-term perioperative treatment with ambroxol reduces pulmonary complications and hospital costs after pulmonary lobectomy: a randomized trial.
Refai M; Brunelli A; Xiumé F; Salati M; Sciarra V; Socci L; Di Nunzio L; Sabbatini A
Eur J Cardiothorac Surg; 2009 Mar; 35(3):469-73. PubMed ID: 19144532
[TBL] [Abstract][Full Text] [Related]
35. Effects of ambroxol on spontaneous or stimulated generation of reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or without chronic obstructive pulmonary diseases.
Teramoto S; Suzuki M; Ohga E; Ishii T; Matsui H; Matsuse T; Ouchi Y
Pharmacology; 1999 Sep; 59(3):135-41. PubMed ID: 10450068
[TBL] [Abstract][Full Text] [Related]
36. Neltenexine tablets in smoking and non-smoking patients with COPD. A double-blind, randomised, controlled study versus placebo.
Cattaneo C
Minerva Med; 2001 Aug; 92(4):277-84. PubMed ID: 11535971
[TBL] [Abstract][Full Text] [Related]
37. [Endothelial dysfunction in patients with combined coronary heart disease and chronic obstructive pulmonary disease].
Grigor'eva NIu; Sharabrin EG; Kontorshchikova KN; Kuznetsov AN; Mazalov KV; Koroleva EF
Klin Med (Mosk); 2009; 87(8):41-4. PubMed ID: 19827529
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the effects of ambroxol on the ofloxacin concentrations in bronchial tissues in COPD patients with infectious exacerbation.
Paganin F; Bouvet O; Chanez P; Fabre D; Galtier M; Godard P; Michel FB; Bressolle F
Biopharm Drug Dispos; 1995 Jul; 16(5):393-401. PubMed ID: 8527688
[TBL] [Abstract][Full Text] [Related]
39. Cardiac safety profile of nebulized formoterol in adults with COPD: a 12-week, multicenter, randomized, double- blind, double-dummy, placebo- and active-controlled trial.
Nelson HS; Gross NJ; Levine B; Kerwin EM; Rinehart M; Denis-Mize K;
Clin Ther; 2007 Oct; 29(10):2167-78. PubMed ID: 18042473
[TBL] [Abstract][Full Text] [Related]
40. [Mortality from chronic obstructive pulmonary disease: a role of comorbidity].
Karoli NA; Rebrov AP
Klin Med (Mosk); 2008; 86(3):18-21. PubMed ID: 18441698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
